2CP-25344-48347
3 vaccinations
10 coded responses
40 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 921 / CA
- Registered
- 2021-07-16
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-16
Registered in v-safe
-
2021-07-16
Dose 1 — Pfizer-BioNTech
-
2021-07-16
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Soreness around injection siteMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Soreness in the arm of injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-07-18
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Fair · Headache, Fatigue or tirednessFree text: Soreness store injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-07-19
- 2021-07-20
- 2021-07-21
- 2021-07-22
- 2021-07-23
- 2021-07-30
- 2021-08-06
-
2021-08-08
Dose 2 — Pfizer-BioNTech
- 2021-08-08
-
2021-08-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-08-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-08-11
-
2021-08-12
Survey response — days 1–6 daily, dose 2MedDRA: Pain in extremity — Feeling: GoodFree text: Arm sorenessMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-22
- 2021-08-29
- 2021-09-05
- 2021-09-12
- 2021-09-19
- 2021-11-07
- 2022-02-06
-
2022-06-15
Dose 3 — Pfizer-BioNTech
-
2022-06-16
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-06-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-06-18
Survey response — days 1–6 daily, dose 3MedDRA: Contusion — Feeling: Good · Site: Pain, Redness · Muscle or body achesFree text: BruisingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-19
Survey response — days 1–6 daily, dose 3MedDRA: Contusion — Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: BruisingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-20
Survey response — days 1–6 daily, dose 3MedDRA: Contusion — Feeling: Fair · Site: PainFree text: BruisingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-21
Survey response — days 1–6 daily, dose 3MedDRA: Contusion — Feeling: GoodFree text: BruisingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-22
Health check-in — day 7, dose 3Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-06-29
- 2022-07-08
- 2022-07-13
- 2022-07-20
- 2022-07-27
- 2022-09-14
-
2022-12-14
Survey response — 6 months, dose 3MedDRA: Cough, Headache, Migraine, Nasal congestion, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose, stuffy nose, headache, migraine, cough, sore throat, congestion.MedDRA releases: 2024-11 · check-in free text available
-
2023-06-17
Survey response — 12 months, dose 3MedDRA: Illness — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-16 | Pfizer-BioNTech | No |
| 2 | 2021-08-08 | Pfizer-BioNTech | No |
| 3 | 2022-06-15 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Soreness around injection site
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Soreness in the arm of injection site
Systemic reaction (other): Soreness store injection site
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Arm soreness
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Bruising
Systemic reaction (other): Bruising
Systemic reaction (other): Bruising
Systemic reaction (other): Bruising
Release 12 — 6 months, dose 3
Symptoms: Runny nose, stuffy nose, headache, migraine, cough, sore throat, congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Contusion | · | · | ✓ |
| SRO | Injection site pain | ✓ | · | ✓ |
| SRO | Pain in extremity | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release